Edwards Lifesciences (EW)
$84.00 1.33 (1.56%)
19:00 EDT EW Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 17.71B
PE Ratio 32.31
Volume (Avg. Vol.) 1.83M
Day's Range 83.23 - 86.73
52-Week Range 66.23 - 247.64
Dividend & Yield N/A (N/A)
EW Stock Predictions, Articles, and Edwards Lifesciences News
- From InvestorPlace
- From the Web
All three of these breakthrough stocks to buy boast strong trends and earnings growth that continues unabated.
We have been managing a position in Boston Scientific (NYSE:BSX) since early mid-February of this year. BSX is a medical device company that manufactures coronary stent systems, cancer treatment catheter systems, Parkinson’s deep brain stimulation systems and more.
These seven healthcare stocks are coming to life Monday. Here's how to play these companies without getting burnt.
3 Stocks to Watch on Wednesday: Edwards Lifesciences Corp (EW), Illumina, Inc. (ILMN) and Tesla Inc (TSLA)
Edwards Lifesciences (EW) and Illumina (ILMN) reported their quarterly earnings results, while Tesla (TSLA) is being accused of stiffing its workers of overtime.
In such fragile market conditions, it pays to keep your portfolio full of solid stocks with consistent growth and a favorable outlook. All of the seven stocks to buy in this article are up on a one-month basis. Some of them by over 10%!
3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), Edwards Lifesciences Corp (EW) and Motorola Solutions Inc (MSI)
Amgen (AMGN) posted underwhelming earnings, Edwards Lifesciences (EW) posts strong 2017 revenue and Motorola Solutions (MSI) expects 2018 EPS to beat estimates.
These ten stocks are currently the most expensive stocks trading on the S&P 500 -- so buyer beware.
Edwards Lifesciences (NYSE:EW) is ranked as a Buy using the methodology for investing of Louis Navellier and his Portfolio Grader stock evaluator. The shares have been upgraded from a Hold to a Buy in the last week.
Portfolio Grader currently ranks Edwards Lifesciences (NYSE:EW) a Buy. The approach to fundamental and quantitative metrics used in this analytical tool, developed by Louis Navellier evaluates and ranks nearly 5,000 stocks each week. EW has been upgraded from a Hold to a Buy in the last week.
With a $21.7 billion market value, Edwards Lifesciences (NYSE:EW) ranks in the top 10% of its industry group, Health Care Equipment & Supplies, and in the top 10% of its sector group, Health Care, in market value. From the viewpoint of investment attractiveness, the ranking for EW by Portfolio Grader places it 76 among the 164 companies in this industry group, placing it in the top half; in the top half of the sector with a ranking of 366 among the 785 companies in the sector, and number 2,386 in the nearly 5,000 company Portfolio Grader universe.
With World Heart Day coming up, here is a look at some well-positioned stocks including BioTelemetry (BEAT) in this segment of the market.
We set out to find the best stock in each sector, using a stock screener to pull up only stocks with a "strong buy" analyst consensus rating.
Why Edwards Lifesciences Corp (EW), Ralph Lauren Corp (RL) and TD Ameritrade Holding Corp. (AMTD) Are 3 of Today’s Worst Stocks
Ralph Lauren (RL), TD Ameritrade (AMTD) and Edwards Lifesciences (EW) unsurprisingly led Thursday's bearish charge.
Why Southwest Airlines Co (LUV), GrubHub Inc (GRUB) and Edwards Lifesciences Corp (EW) Are 3 of Today’s Worst Stocks
Owners of GrubHub (GRUB), Edwards Lifesciences (EW) and Southwest Airlines (LUV) couldn't wait for hump-day to end.
The grades of 9 Health Care Equipment & Supplies stocks are on the rise this week on Portfolio Grader. Each of these stocks is rated an "A" ("strong buy") or "B" overall ("buy").
If you've used my Portfolio Grader tool you know I put weight on what analysts are saying about stocks. Here are 6 picks based on that analysis
These best stocks of the past decade would have made you awfully rich ... but do they still have any upside left?
The Week Ahead In Biotech: Spectrum Pharma FDA Decision, Biogen And Abbott Earnings, Cancer Conference
From Market News Video
Navellier RatingsPowered by Portfolio Grader